home login register your profile contact        
Affymetrix  
Products Support Analysis Scientific Community Corporate Affymetrix Japan
About the Company
Investors
Compliance
Newsroom
Events
Careers
Licensing
Outreach
Press Releases: All 2005 2004 2003 2002
  2001 2000 1999 1998 1997
Search Press Releases
 

Date Title  (click to view the full text)
10/27/09 Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET(TM) Plus Panel
10/21/09 Affymetrix Reports Third Quarter 2009 Results
10/14/09 Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study
10/14/09 Affymetrix Launches New Platform for Next-Generation Genotyping
10/7/09 Affymetrix to Host Conference Call on October 21, 2009 to Announce Third Quarter 2009 Results
9/1/09 Affymetrix to Webcast Presentations at September Financial Conferences
8/26/09 Affymetrix and Beckman Coulter Join Forces to Provide Robust, Automated Target Preparation Solutions
8/5/09 The NIAID-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix Array for Faster Identification of E. Coli and Shigella
7/22/09 Affymetrix Reports Second Quarter 2009 Results
7/8/09 Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results
6/11/09 Affymetrix to Webcast Annual Meeting of Shareholders
6/2/09 Key Milestones to Improve Operating Leverage Achieved Ahead of Schedule
5/29/09 Affymetrix Chief Medical Officer to speak at AAAS on Personalized Medicine
5/28/09 Entrepreneur Magazine Picks Affymetrix as One of Top 100 Companies to Watch
5/20/09 Affymetrix to Webcast Investor Day 2009
5/11/09 Affymetrix Appoints Gary Guthart to Board of Directors
5/5/09 Affymetrix to Webcast Presentations at May Financial Conferences
4/30/09 Affymetrix Chosen as One of the Top Places to Work in the Bay Area
4/22/09 Affymetrix Reports First Quarter 2009 Results
4/22/09 Six New Genes Associated with Heart Attacks
4/14/09 Affymetrix to Host Conference Call on April 22, 2009 to Announce First Quarter 2009 Results
3/25/09 New Cytogenetics Products Offer Best Overall Approach for Detection of Chromosome Aberrations
3/16/09 Affymetrix and Genisphere Launch Best-in-Class Solution for microRNA Expression Research
3/4/09 Affymetrix to Webcast Presentations at Two March Financial Conferences
1/28/09 Affymetrix Reports Fourth Quarter and Fiscal Year 2008 Results
1/27/09 Affymetrix to Host Conference Call on January 28, 2009 to Announce Fourth Quarter and Fiscal 2008 Results
1/15/09 Coriell Institute for Medical Research Selects Affymetrix DMET Plus Product for National Personalized Medicine Project
1/8/09 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
12/9/08 Affymetrix Technology Powers Cincinnati Children's Hospital's Innovative Test for Jaundice
12/8/08 Affymetrix Completes Acquisition of Panomics
12/1/08 Researchers Use Affymetrix Technology to Discover Why Some Breast Cancer Patients Resist Tamoxifen
11/26/08 Affymetrix to Webcast Presentation at Piper Jaffray Healthcare Conference
11/11/08 Affymetrix to Acquire Panomics
11/11/08 Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies
10/23/08 Affymetrix Reports Third Quarter 2008 Results
10/22/08 Affymetrix Founder and CEO Announces Succession Plan
10/20/08 Affymetrix Appoints Rick Runkel to Executive Vice President and General Counsel
10/13/08 Affymetrix Announces Preliminary Third Quarter Revenue
10/7/08 South African Core Lab Adopts Affymetrix Technology for Genomic Studies
10/3/08 Wall Street Journal Selects PhyloChip Developed on the Affymetrix Platform as a Top Technology Innovation
10/1/08 Affymetrix and Medical Prognosis Institute Collaborate to Develop Cancer Treatment Products
9/29/08 Affymetrix' GeneTitan(TM) System Delivers Automatic Answers and Sets New Standard in Genomic Analysis
9/25/08 Wellcome Trust Sanger Institute Uses Affymetrix Technology to Reveal Changes in 800 Cancer Cell Lines
9/16/08 Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
9/3/08 Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation
8/29/08 Affymetrix to Webcast Presentations at Two September Financial Conferences
8/13/08 Affymetrix Technology Helps Advance Schizophrenia Research
7/31/08 Affymetrix to Webcast Presentation at Leerink Swann Life Sciences Tools Conference
7/31/08 Affymetrix Microarray Platform Granted Clearance from FDA for Gene Expression Diagnostic Testing
7/24/08 Wellcome Trust Case Control Consortium and Affymetrix Expand World's Largest Study of Genetic Diseases
7/24/08 Affymetrix Reports Second Quarter 2008 Results
7/10/08 Affymetrix to Host Conference Call on July 24, 2008 to Announce Second Quarter 2008 Results
7/8/08 Affymetrix and Asuragen Sign Agreement to Develop IVT Reagent Kits for Molecular Diagnostic Applications
6/30/08 Affymetrix Technology Used to Discover Molecular Mechanisms of Liver Disease
6/16/08 Center for Inherited Disease Research Adds Affymetrix Platform for Large-Scale Genotyping Services
6/9/08 Case Western Reserve University and TGen Select Affymetrix SNP Array 6.0 for Diabetes Study
5/30/08 Affymetrix Technology Powers First Genomic Tumor Grading Test for Breast Cancer
5/21/08 Affymetrix Applauds Congress and President for Enacting the Genetic Information Nondiscrimination Act
5/19/08 Korea NIH Expands KARE Project with Second Affymetrix Technology Order
5/12/08 LineaGen Selects Affymetrix Technology to Discover Genes Associated With Autism and Multiple Sclerosis
4/29/08 Affymetrix to Webcast Presentations at May Financial Conferences
4/24/08 Affymetrix Reports First Quarter 2008 Results
4/22/08 Affymetrix Technology Powers Innovative Pathwork(R) Diagnostics, Inc. Cancer Test
4/15/08 Affymetrix Extends Collaborations in Cancer Research Program to North America
4/14/08 Affymetrix Announces Preliminary First Quarter Revenue
3/24/08 Affymetrix Signs Agreement With Avesthagen Limited
3/13/08 Affymetrix Announces Launch of New Cytogenetic Solution
3/10/08 Affymetrix to Webcast Presentations at Two March Financial Conferences
3/6/08 Affymetrix Named One of the World's Top 50 Innovative Companies
2/7/08 Marshfield Clinic Research Team Uses Affymetrix DMET Solution to Discover Genetic Variant Affecting Warfarin Metabolism in Patients
1/31/08 Affymetrix Reports Fourth Quarter and Fiscal Year 2007 Results
1/31/08 Affymetrix Completes Acquisition of USB Corporation
1/30/08 Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
1/28/08 LabCorp to Use Affymetrix Technology for Molecular Cytogenetic Service Offering
1/24/08 Affymetrix Launches World's Most Comprehensive Solution for Clinical Drug Metabolism Studies
1/24/08 Clinical Data and Affymetrix Announce Marketing Agreement for New Drug Metabolism Service
1/17/08 Affymetrix to Host Conference Call on January 31, 2008 to Announce Fourth Quarter and Fiscal Year 2007 Results
1/15/08 Affymetrix Launches Industry's Most Complete Line of Custom Arrays for Plant and Animal Genomes
1/10/08 Affymetrix and Illumina Settle Their Patent Disputes
1/2/08 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
12/18/07 Affymetrix to Acquire USB Corporation
12/17/07 Affymetrix Simplifies Copy Number Data Analysis for Association and Cytogenetic Studies
12/13/07 Affymetrix Announces $41,250,000 Senior Convertible Notes Over-Allotment Closing
12/13/07 Canada's Leading Cardiovascular Center Uses Affymetrix SNP Array 6.0 to Replicate Whole-genome Association Study Findings
12/5/07 The Coriell Institute for Medical Research Selects Affymetrix SNP Array 6.0 for Delaware Valley Personalized Medicine Project
11/20/07 Affymetrix to Webcast Presentation at Piper Jaffray Health Care Conference
11/16/07 Affymetrix Closes $275 Million Senior Convertible Notes Offering
11/13/07 Affymetrix Announces Pricing of Offering of Senior Convertible Notes Due 2038
11/13/07 Affymetrix Announces Proposed $250 Million Offering of Senior Convertible Notes Due 2038
11/6/07 Affymetrix GeneChip(R) Command Console(R) Software Simplifies Microarray Processing and Analysis Workflows
11/6/07 Navigenics Launches With Preeminent Team of Advisers, Partners and Investors
10/29/07 Affymetrix to Webcast Presentation at JPMorgan SMid Cap Conference
10/24/07 Affymetrix Files Second Wave of Patent Infringement Lawsuits Against Illumina in United States and Europe
10/24/07 Affymetrix Reports Third Quarter 2007 Results
10/17/07 Affymetrix Launches Microarray Data Analysis Training University
10/10/07 Affymetrix to Host Conference Call on October 24, 2007 to Announce Third Quarter 2007 Results
10/9/07 Affymetrix Scientists Awarded $10.2 Million Grant from NHGRI for Four-year Follow-up ENCODE Study
10/2/07 Affymetrix Technology Used to Discover Common Genetic Variant Associated with Height Variation
10/1/07 Affymetrix Hosts Two Cancer Genomics Workshops at 2007 NCRI Conference
9/18/07 Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
9/18/07 Affymetrix Promotes Kevin King to Company President
9/17/07 Affymetrix Hosts Pharmacogenetics Workshop at Discovery 2 Diagnostics Conference
9/12/07 Second Beckman Coulter Biomek(R) Platform Awarded Premier Application Status by Affymetrix
9/10/07 Affymetrix Adds Mouse and Rat Arrays to Gene 1.0 ST System
9/7/07 Affymetrix and Empire Genomics Enter Into Licensing Agreement
8/29/07 Affymetrix to Webcast Presentations at Two September Financial Conferences
8/28/07 Affymetrix and IPSOGEN Collaborate to Develop and Market In-Vitro Diagnostic Cancer Tests
8/2/07 Affymetrix to Webcast Presentation at Leerink Swann Life Sciences Tools Conference
8/1/07 Dr. Lubert Stryer Awarded 2006 National Medal of Science
7/25/07 Affymetrix Reports Second Quarter 2007 Results
7/25/07 Children's Hospital of Philadelphia Selects Affymetrix SNP Array 6.0 for Series of Whole-genome Association Studies across 7,000 Samples
7/23/07 Partners HealthCare and Affymetrix Sign New Agreement to Accelerate Personalized Medicine
7/19/07 The Wellcome Trust Case Control and Cardiogenics Consortiums Identify Key Genes in Coronary Artery Disease with Affymetrix Technology
7/18/07 Affymetrix to Host Conference Call on July 25, 2007 to Announce Second Quarter 2007 Results
7/17/07 Affymetrix and Children's Research Institute Form Five-year Strategic Alliance
7/16/07 Affymetrix Clinical Services Laboratory and DOCRO Join Forces to Accelerate the Commercialization of In Vitro Diagnostic Products
7/9/07 Affymetrix Launches European Cytogenetic Research Initiative
7/2/07 Genetic Association Information Network Selects Affymetrix SNP Array 6.0 for Latest Series of Studies
6/13/07 Affymetrix Scientists and Technology Help Decipher the Encyclopedia of Functional DNA Elements
6/12/07 Affymetrix to Webcast Presentations at the NASDAQ 19th Investor Healthcare Forum
6/12/07 Korea NIH to Use Affymetrix Technology for Groundbreaking Genome-Wide Association Study
6/7/07 Wellcome Trust Case Control Consortium Completes World's Largest Whole-genome Association Project Using Affymetrix Technology
6/6/07 Research Team Identifies New Alzheimer's Gene
6/6/07 Affymetrix Appoints John Batty to Chief Financial Officer and Executive Vice President
6/6/07 Affymetrix to Webcast Annual Meeting of Shareholders
6/5/07 Affymetrix Arrays Used to Identify Gene Amplification Associated with Breast Cancer
6/1/07 Affymetrix to Webcast Presentation at Bank of America Health Care Conference
5/23/07 Affymetrix Celebrates Grand Opening of Singapore Manufacturing Facility
5/21/07 Affymetrix Sets New Standard in Genotyping With Genome-Wide Human SNP Array 6.0
5/17/07 Affymetrix High-Resolution Tiling Arrays Continue to Redefine Genome Function
5/17/07 Affymetrix to Webcast Presentations at Two May Financial Conferences
5/3/07 Affymetrix Introduces Targeted Genotyping Bovine 25K SNP Service to Improve Quality of Dairy and Beef Cattle
5/2/07 Affymetrix to Webcast Presentation at Baird Growth Stock Conference
4/26/07 German National Genome Research Network to Analyze More Than 17,000 DNA Samples Using Affymetrix Technology
4/25/07 Affymetrix Reports First Quarter 2007 Results
4/25/07 Agencourt, Affymetrix Clinical Services Lab and NuGEN Technologies Collaborate to Accelerate Automated Clinical Whole Blood Sample Expression Profiling on GeneChip(R) Microarrays
4/25/07 Affymetrix to Webcast Presentation at Deutsche Bank Health Care Conference
4/23/07 Affymetrix Clinical Services Laboratory Receives CLIA Certification
4/18/07 Affymetrix to Host Conference Call on April 25, 2007 to Announce First Quarter 2007 Results
4/17/07 Affymetrix and NuGEN Announce Agreement to Co-market the NuGEN WT-Ovation(TM) FFPE System
4/16/07 Affymetrix Launches Program to Advance Cancer Research
4/3/07 Latest Affymetrix Microarray Offers New Users a Cost-effective and Easy-to-use Alternative for Gene-level Expression Profiling
3/27/07 Affymetrix Automated Microarray Processing Platform Analyzes up to 96 Samples at a Time
3/19/07 Affymetrix Appoints Robert Wayman to Board of Directors
3/13/07 Affymetrix Granted Favorable Verdict in Patent Infringement Case Against Illumina
3/13/07 Affymetrix to Webcast Presentation at Lehman Brothers Healthcare Conference
3/1/07 Affymetrix to Webcast Presentations for UBS West Coast Life Sciences & Diagnostics Tour
2/21/07 Affymetrix to Webcast Presentation at Bear Stearns London Healthcare Conference
2/20/07 Affymetrix Releases Its Most Comprehensive Single Array for Genetic Studies
2/7/07 Affymetrix Reports Fourth Quarter and Fiscal Year 2006 Results
2/6/07 UPDATE on Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2/1/07 Affymetrix to Host Conference Call on February 7, 2007 to Announce Fourth Quarter and Fiscal Year 2006 Results
2/1/07 Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
1/24/07 Affymetrix Signs Three-Year Translational Medicine Agreement With Vanderbilt-Ingram Cancer Center
1/23/07 Affymetrix and Tessarae Collaborate to Help Researchers Better Respond to Biodefense and Pandemic Infectious Disease Threats
1/8/07 Affymetrix Redefines Association Studies with Introduction of SNP 5.0 Array
1/8/07 Affymetrix Announces Fourth Quarter Total Revenue of Approximately $100 Million
12/21/06 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
12/19/06 Affymetrix Names Kevin King President of Life Sciences Business
12/14/06 Affymetrix Announces Change in Executive Management Team
12/13/06 Affymetrix and Sysmex Join Forces to Develop and Market In-Vitro Diagnostic Tests
12/5/06 Affymetrix and Baylor College of Medicine Enter into Licensing Agreement
11/30/06 Scan of Entire Human Genome Finds Unexpected New Clues on Lou Gehrig's Disease
11/29/06 Genetic Age Symposium: The Era of Personalized Medicine
11/27/06 Affymetrix 500K Array Used to Generate First Copy Number Variation Map of the Human Genome
11/22/06 Affymetrix to Webcast Presentation at Piper Jaffray Health Care Conference
11/8/06 Affymetrix to Webcast Presentations at Two November Financial Conferences
11/7/06 Affymetrix and Iconix Co-Develop Comprehensive Toxicogenomics Research Tool
10/25/06 Affymetrix Reports Third Quarter 2006 Results
10/24/06 Wyeth Extends Agreement with Affymetrix to 15 Years
10/19/06 Affymetrix 500K Array Used to Identify Memory Gene
10/16/06 Affymetrix to Host Conference Call on October 25, 2006 To Announce Third Quarter 2006 Results
10/11/06 Affymetrix Appoints Masao Yoneyama as General Manager of Japan Operations
10/10/06 Genetic Association Information Network announces genotyping awards for six common diseases
10/9/06 First African American Genome Scan for Disease Genes Will Use Affymetrix 500K Arrays
10/6/06 Affymetrix and NimbleGen Systems Enter into Licensing Agreement
9/27/06 Peter MacCallum Cancer Centre and Affymetrix Initiate Five-Year Translational Research Collaboration
9/20/06 Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
9/18/06 Affymetrix Signs First Translational Medicine Agreement in China; Zhejiang University to Use GeneChip(R) Microarray Technology to Better Detect, Classify, Manage and Treat Cancer and Infectious Diseases
9/8/06 Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use; GeneChip(R) Technology Demonstrates Top Performance in MicroArray Quality Control Study
9/7/06 Partners HealthCare and Affymetrix Collaborate to Develop Microarray Diagnostics; Research Team to Create and Validate Genetic Tests Based on Affymetrix GeneChip(R) Technology in CLIA Laboratories
9/5/06 Affymetrix Selected to Genotype More Than 9,000 Framingham Heart Study Samples; SHARE Project to Help Identify Genetic Variants Associated With Heart, Lung, Blood and Sleep Disorders
8/31/06 Affymetrix to Webcast Presentations at Two September Financial Conferences
8/30/06 Affymetrix Files Restated Financial Statements
8/30/06 Affymetrix Launches Beta Version of Next-generation Instrument Control Software; GeneChip(R) Command Console(TM) Software Now Available for Download
8/17/06 Judge Issues Markman Order in Affymetrix Litigation with Illumina
8/17/06 Affymetrix Announces Update Regarding Stock Option Grants
8/15/06 Affymetrix Technology Selected for World's Most Comprehensive Genetic Study on Autism; Autism Consortium Will Use Single GeneChip(R) Human Mapping 500K Array to Help Identify Genetic Causes Across 3,700 Samples
8/9/06 Affymetrix Announces Update Regarding Stock Option Grants
8/2/06 Affymetrix Control Program Advances Association Studies and Saves Researchers Time and Money; World's Largest Population Genetics Control Resource Will Provide Free Public Access to Genotype Data on More Than 12,000 Samples
7/31/06 Affymetrix Reports Second Quarter 2006 Results
7/27/06 CapitalBio Corporation to Offer Genotyping Services Using Affymetrix 500K Array in China; Company Earns Affymetrix Service Provider Certification
7/27/06 Affymetrix to Webcast Presentation at Baird Oncology Conference
7/20/06 Affymetrix to Host Conference Call on July 31, 2006 to Announce Second Quarter 2006 Results
7/18/06 Affymetrix to Introduce 1 Million-SNP Product in Early 2007 and Single 500K Array before End of 2006; Affymetrix and Broad Institute Collaborate to Increase Power of Whole-Genome Association Studies
7/10/06 Affymetrix Launches New Publication for Microarray Research; Website Features Articles on All Aspects of Microarray-Based Experiments
6/27/06 Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement
6/21/06 Affymetrix and Invitrogen Enter Into Licensing Agreement
6/16/06 Updated - Affymetrix to Webcast Presentation at the Nasdaq 17th Investor Program Healthcare Forum
6/16/06 Affymetrix to Webcast Presentation at the Nasdaq 17th Investor Program Healthcare Forum
6/8/06 Affymetrix to Webcast Annual Meeting of Shareholders
5/17/06 Affymetrix Inventors Named European Inventors of the Year; European Patent Office Recognizes Microarray Invention
5/3/06 Affymetrix to Webcast Presentation at Baird 2006 Growth Stock Conference
4/26/06 Affymetrix to Webcast Presentation at Deutsche Bank Health Care Conference
4/24/06 Scientists Develop New Methods to Integrate and Analyze Microarray Data from Whole-Genome Association Studies -- April 24, 2006 Issue of Affymetrix Microarray Bulletin Now Available
4/20/06 Affymetrix Reports First Quarter 2006 Results
4/19/06 Affymetrix Announces Management Changes
4/13/06 Affymetrix to Host Conference Call on April 20, 2006 to Announce First Quarter 2006 Results
4/5/06 Affymetrix and Abbott Enter Into Licensing Agreement
3/27/06 Affymetrix Announces New ChIP-on-Chip Array Product Line; New Whole-Genome Tools Help Scientists Discover DNA-Protein Interactions
3/21/06 Affymetrix to Webcast Presentations for UBS West Coast Life Sciences & Diagnostics Tour
3/8/06 Korea's National Institute of Health to Use Affymetrix 500K Array Set for Genome-Wide Association Studies; Collaboration to Identify Genes Associated With Diabetes, Hypertension, Asthma and Metabolic Syndrome
3/2/06 Affymetrix to Webcast Presentation at Lehman Brothers Healthcare Conference
2/21/06 Affymetrix to Webcast Presentation at Citigroup 2006 Healthcare Conference
2/15/06 Affymetrix Appoints Robert Trice to Board of Directors
2/15/06 Affymetrix Microarrays Used to Study Tuberculosis and Malaria; AMB Features Two Interviews With Researchers From Imperial College London and Scripps Research Institute
2/7/06 Affymetrix and Iconix Collaborate to Develop New Solutions for Assessing Drug Toxicity
2/1/06 Affymetrix to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2/1/06 Affymetrix Microarrays Used to Detect Heart and Kidney Transplant Rejection Without Biopsy; AMB Features Two Interviews With Researchers From the University of Pennsylvania and the Scripps Research Institute
1/26/06 Affymetrix Reports Fourth Quarter and Fiscal Year 2005 Results; Consumables Drive Revenue Growth
1/24/06 New Affymetrix Tiling Arrays Deliver Unbiased View of Entire Genomes; Recent Experiments Using GeneChip(R) Microarrays Challenge Concept of ''Junk'' DNA
1/19/06 Affymetrix to Host Conference Call on January 26, 2006 to Announce Fourth Quarter and Fiscal Year 2005 Results
1/18/06 Affymetrix Microarrays Used to Detect Thousands of Pathogens, Including Anthrax and Plague; AMB Features Two Interviews with Researchers from Lawrence Berkeley National Laboratory and Naval Medical Research Center
1/9/06 Duke University and Affymetrix Initiate Five-Year Translational Research Collaboration
1/5/06 Affymetrix Updates Revenue Outlook for Fourth Quarter; Year-end Instrument Sales Below Company Expectations
1/2/06 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
12/26/05 Affymetrix and Vita Genomics Collaborate to Develop Microarray-based IVD Products
12/20/05 New Affymetrix Microarray Sequences Complete Mitochondrial Genome in a Single 48 Hour Experiment
12/19/05 Affymetrix Launches Industry's Broadest-Selection of Standard and Custom SNP Panels for Targeted Genotyping Applications; Highly Multiplexed Assays Provide Data On 1,500 to 20,000 Selected SNPs
12/14/05 Affymetrix Forms Research Alliance With Imperial College London and the Medical Research Council; Collaboration to Identify Genes Associated with Cardiovascular Disease, Diabetes and Cancer
11/22/05 Affymetrix to Webcast Presentation at Wall Street Analyst Forum
11/11/05 Affymetrix to Webcast Presentations at Two November Financial Conferences
11/1/05 Affymetrix and PathWork Informatics Forge Collaboration to Develop New Cancer Diagnostics
10/25/05 Affymetrix and CureSearch Children's Oncology Group to Discover and Validate Gene Expression Signatures for Common Childhood Cancers
10/24/05 Affymetrix Completes Acquisition of ParAllele BioScience; Companies Combine Their Innovative Technologies to Enable Advances in Genomic Discovery and Delivery of New Healthcare Diagnostics
10/20/05 Affymetrix Reports Third Quarter 2005 Results
10/12/05 Affymetrix to Host Conference Call on October 20, 2005 to Announce Third Quarter 2005 Results
10/10/05 CapitalBio and Affymetrix to Support and Promote Rice Functional Genomic Research in China
10/10/05 Doctors in Pennsylvania Dutch Country Find New Genetic Links to Half Dozen Diseases in Past Year
10/5/05 Wellcome Trust Case Control Consortium Partners With Perlegen and Affymetrix to Search for Genetic Origins of Ten Complex Diseases
10/5/05 Jeffrey Modell Foundation, NHGRI and Affymetrix to Develop Newborn Screening Tests; Joint Research Project Will Focus on Early Detection of Primary Immunodeficiencies
10/4/05 GlaxoSmithKline to Conduct Whole-Genome Association Studies Using Affymetrix Technology; Companies Sign Multi-Year Agreement for GeneChip(R) Human Mapping 500K Array Set
10/3/05 Affymetrix Launches GeneChip(R) Human Exon Array; -- New Microarray Offers Exon-Level, Genome-Wide Expression Profiling on a Single Array --
9/28/05 Affymetrix Launches Automated Target Preparation and Microarray Processing System; GeneChip(R) Array Station Offers Enhanced Data Consistency and Reduces the Overall Cost of Large-Scale Studies
9/28/05 New Affymetrix Microarray Set Genotypes More Than 500,000 SNPs in a Single Experiment; GeneChip(R) Human Mapping 500K Array Set Enables Researchers to Perform Highly Detailed Whole-Genome Association Studies for the First Time
9/27/05 Affymetrix Updates Revenue Outlook for Third Quarter; Manufacturing Yields Affect Shipment of High Demand Product
9/21/05 Affymetrix to Webcast Presentation at UBS Warburg Conference
9/13/05 Affymetrix Launches GeneChip-compatible(TM) Applications Program; Program Underscores Company's Commitment to Supporting Customers with Integrated Microarray Solutions
9/4/05 Affymetrix Microarrays Uncover Genetic Mutations in Embryonic Stem Cells Approved for Federally-Funded Research; Scientists Report That Majority of Cells Develop Mutations Over Time
8/31/05 Affymetrix to Webcast Presentations at Two September Financial Conferences
7/21/05 Affymetrix Reports Second Quarter 2005 Results
7/21/05 Broad Institute to Conduct Large-Scale Genotyping Project Using Affymetrix Technology
7/14/05 Affymetrix to Host Conference Call on July 21, 2005 to Announce Second Quarter 2005 Results
6/13/05 Affymetrix and ParAllele Launch Industry's Most Comprehensive Product Line for Targeted Genotyping
6/13/05 New Affymetrix GeneChip(R) Scanner Analyzes Up to Five Times More Data
6/7/05 Affymetrix to Webcast Presentations at Two June Financial Conferences
6/1/05 Affymetrix to Webcast Presentation at the Pacific Growth Equities 2005 Life Sciences Growth Conference
5/31/05 Affymetrix Signs Agreement to Acquire ParAllele BioScience
5/12/05 Affymetrix to Webcast Presentation at the Nasdaq 15th Investor Program Healthcare Forum
5/3/05 Affymetrix to Webcast Presentation at the Robert W. Baird 2005 Growth Stock Conference
4/26/05 CapitalBio Corporation and Affymetrix Announce Strategic Relationship
4/25/05 Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
4/21/05 Affymetrix Reports First Quarter 2005 Results
4/14/05 Affymetrix to Host Conference Call on April 21, 2005 to Announce First Quarter 2005 Results
4/12/05 Affymetrix Launches New GeneChip(R) Globin-Reduction Kits and Protocol Developed with PreAnalytiX
4/5/05 Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
3/24/05 New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
3/24/05 Affymetrix to Webcast Presentation at the Lehman Brothers Global Healthcare Conference
3/17/05 Serono Identifies 80 Genes Involved in Multiple Sclerosis Using Affymetrix 100K SNP Arrays
2/16/05 Harvard Medical School - Partners HealthCare Center for Genetics and Genomics to Launch Major Genotyping Study in Atherosclerosis with Affymetrix Technology
2/8/05 Karolinska Institutet and Affymetrix Announce Translational Medicine Strategic Alliance
2/7/05 Affymetrix and Stratagene Announce Strategic Software Alliance
2/2/05 Institut Curie and Affymetrix Launch Strategic Alliance to Study Cancer
2/1/05 Affymetrix to Webcast Presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
1/27/05 Scientists Find Genome Structure Responsible for Gene Activation
1/26/05 Affymetrix Reports 2004 Fourth Quarter and Full-Year Results
1/20/05 Affymetrix to Webcast Presentation at U.S. Bancorp Piper Jaffray Health Care Conference
1/19/05 Affymetrix to Host Conference Call to Announce Fourth Quarter and Fiscal Year 2004 Results
1/17/05 Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
1/5/05 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
1/5/05 Affymetrix Announces Record Fourth Quarter Revenue of More Than $100 Million
12/28/04 Affymetrix Supplies GeneChip® Technology to Veridex for Cancer Diagnostics Development
12/27/04 Affymetrix Microarray System Cleared by FDA
11/22/04 Affymetrix Appoints Susan Desmond-Hellmann to Board of Directors
11/18/04 HUGO Pacific Pan-Asian SNP Initiative to Explore Genetic Diversity for Nearly Half the World's Population
11/15/04 Affymetrix Launches Most Comprehensive Array Offering for Microbiology Research
11/10/04 Genospectra Takes a Commercial License to Affymetrix Bead Patents
11/10/04 Affymetrix to Webcast Presentations at November Financial Conferences
10/27/04 Affymetrix Genotyping Arrays Help Researchers Understand Genetic Basis of Disease
10/22/04 Affymetrix Launches ENCODE Array to Uncover Hidden Function of Human Genome
10/20/04 Affymetrix Reports Third Quarter 2004 Results
10/19/04 New Pathogen Identification Microarray to Offer Most Comprehensive Single Test for Biodefense
10/13/04 Affymetrix to Host Conference Call to Announce Third Quarter 2004 Results
10/12/04 Affymetrix Launches Updated E. coli and Yeast Whole Genome Arrays
10/4/04 Affymetrix Recognized with R&D 100 Award
9/22/04 Affymetrix to Webcast Presentation at UBS Warburg Conference
9/22/04 Affymetrix and Broad Institute Collaborate on Landmark Research Projects
9/21/04 Affymetrix Technology to Be Used in Groundbreaking Studies of Neurological Disease
9/20/04 Affymetrix Recognized with Outstanding Corporate Innovator Award by Product Development & Management Association
9/15/04 Affymetrix to Host Live Webcast of Investor Day 2004
9/1/04 Affymetrix to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
9/1/04 World's First Diagnostic Microarray System Launched by Affymetrix in European Union
8/31/04 Affymetrix Achieves ISO Certification for Instrumentation and Microarray Manufacturing Facilities
8/4/04 EPA Signs Research Agreement to Develop Improved Tests for Identifying Hazardous Chemicals (EPA release)
7/27/04 Erasmus MC to Use Affymetrix Technology in Comprehensive Translational Medicine Initiative
7/21/04 Affymetrix Reports Second Quarter 2004 Results
7/20/04 Affymetrix, ParAllele and Cambridge University Collaborate For Large-Scale Genetic Study of Diabetes
7/19/04 Researchers Identify Gene for a Primary Form of Sudden Infant Death Sydrome (SIDS)
7/19/04 NAAR Launches Largest Autism Genetics Study
7/14/04 Affymetrix to Host Conference Call on July 21, 2004 to Announce Second Quarter 2004 Results
7/6/04 Affymetrix and Perlegen to Offer Research Community Access to Custom Genotyping Services
6/28/04 Affymetrix Launches New Arrays for SNP Genotyping Studies
6/21/04 Affymetrix Launches New Custom Array Design Options
6/16/04 Affymetrix Genotyping Arrays Identify Chromosomal Changes Not Detectable by Comparative Genomic Hybridization
6/10/04 Affymetrix to Present at Thomas Weisel Partners Growth Forum 6.0
6/7/04 Rockefeller University to Study Genetic Roots of Obesity-Related Diseases Via Whole Genome Association Scans
6/3/04 Affymetrix to Webcast Annual Meeting of Stockholders
5/19/04 Affymetrix and ParAllele Partner to Offer New Custom and Standard Genotyping Products
5/14/04 Affymetrix to Webcast Presentation at the Banc of America Securities Health Care Conference
5/5/04 Affymetrix to Webcast Presentation at the NASDAQ 12th Investor Program - Life Sciences Forum
4/28/04 Affymetrix to Webcast Presentation at the Baird 2004 Growth Stock Conference
4/21/04 Affymetrix Affirms 2004 Guidance
4/21/04 Affymetrix Reports First Quarter 2004 Results
4/14/04 Affymetrix to Host Conference Call on April 21, 2004 to Announce First Quarter 2004 Results
4/6/04 Affymetrix Resequencing Array Classifies Previously Nontypeable Meningitis Strains in Study by UK Health Protection Agency
4/5/04 Affymetrix Announces Expanded Genomic Technologies Licensing Program
4/5/04 New Affymetrix Arrays with 100,000 SNPs Available for Early Technology Access Customers
3/31/04 NHGRI and UC Davis to Conduct Large Scale SNP Discovery in Drosophila melanogaster Using Affymetrix Arrays
3/31/04 New Evidence for Whole Genome Linkage in Bipolar Disorder
3/30/04 IBM and Affymetrix Team to Deliver Tools to Accelerate Information-Based Medicine
3/22/04 Affymetrix Launches Single Rat Array for Whole-Genome Expression Analysis
3/17/04 Affymetrix Launches Updated Whole-Genome Drosophila Array for Gene Expression Analysis
3/3/04 Affymetrix Provides Aventis Pharmaceuticals Early Access to High-Throughput GeneChip(R) Platform
2/25/04 Affymetrix to Webcast Presentation at the Lehman Brothers Global Healthcare Conference
2/19/04 Affymetrix Announces Completion of Smallpox Array Set Developed with CDC
2/11/04 TGen and Affymetrix Partner to Use GeneChip(R) DNA Analysis Products in Major Collaborative Programs
1/28/04 Affymetrix Reports Record Product Revenue and Profit
1/28/04 Affymetrix and Invitrogen Corporation Launch Reagents for GeneChip(R) Expression Array Platform
1/27/04 Affymetrix to Webcast Presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
1/22/04 Affymetrix to Webcast Presentation at U.S. Bancorp Piper Jaffray Health Care Conference
1/21/04 Affymetrix to Host Conference Call to Announce Fourth Quarter and Fiscal 2003 Results
1/21/04 Affymetrix Announces Launch of Zebrafish and Xenopus laevis Arrays for Whole-Genome Expression Analysis
1/20/04 Affymetrix, Inc. Announces Repurchase of 4 3/4% Convertible Subordinated Notes Due 2007
1/13/04 Affymetrix Launches Plasmodium/Anopheles Genome GeneChip(R) Array for Malaria Study
1/13/04 Affymetrix and Caliper Life Sciences Collaborate on Instrument Automation for Target Preparation
1/12/04 Affymetrix Launches Consortia Design Program to Create Whole-Genome Arrays for Plant and Animal Research Communities
1/5/04 Affymetrix to Webcast Presentation at JPMorgan Healthcare Conference
12/10/03 Affymetrix and NuGEN Collaborate to Advance Whole Transcript Analysis
12/10/03 Affymetrix, Inc. Announces Pricing of $100 Million 0.75% Senior Convertible Notes
12/10/03 Affymetrix, Inc. Announces Repurchase of 5% Convertible Subordinated Notes Due 2006
12/8/03 Affymetrix, Inc. Announces Intention to Offer $100 Million Senior Convertible Notes
12/4/03 Affymetrix Enters into Collaboration with Arcturus to Enable Gene Expression Analysis on Paraffin-Embedded Tissues
12/3/03 Affymetrix Launches Single Array for Mouse Genome Expression Analysis
11/6/03 Affymetrix to Webcast Presentations at November Financial Conferences
10/31/03 PreAnalytiX and Affymetrix Collaborate to Improve Gene Expression Results from Whole Blood RNA Samples
10/29/03 Affymetrix Continues Supply of Labeling Reagents
10/22/03 Affymetrix Technology Selected for Next Phase of Human Genome Project
10/22/03 Affymetrix Reports Record Product Revenue and Profit
10/20/03 Affymetrix and bioMerieux Expand Collaboration Agreement
10/13/03 Affymetrix to Host Conference Call to Announce Third Quarter 2003 Results
10/9/03 Affymetrix Releases Data for 120,000 Validated SNPs Into Public Domain
10/2/03 Affymetrix Announces Commercial Launch of Single Array for Human Genome Expression Analysis
9/24/03 Affymetrix Provides Johnson & Johnson Pharmaceutical Research & Development Early Access to New High-Throughput GeneChip(R) Platform
9/23/03 Affymetrix Launches GeneChip(R) AutoLoader for the GeneChip(R) Scanner 3000 System
9/17/03 Affymetrix to Webcast Presentation at UBS Global Life Sciences Conference
9/3/03 GeneChip(R) CustomExpress(TM) 11-Micron Array Format Sets New Standard for Data Capacity: 61,000 Transcripts on a Single Array
8/29/03 Affymetrix to Present at Thomas Weisel Partners Healthcare Tailwinds 2003 Conference
8/11/03 Affymetrix Launches Co-Marketing Partnership with Ingenuity Systems And Purchases Stake in Company
7/23/03 Affymetrix Reports Record Instrument Revenue
7/23/03 Affymetrix Launches Mapping 10K Array and CustomSeq(TM) Resequencing Array
7/14/03 Affymetrix to Host Conference Call to Announce Second Quarter 2003 Results
7/2/03 Affymetrix Launches New GeneChip(R) Barley Genome Array
6/23/03 Affymetrix, NIAID and TIGR Join Forces to Fight SARS Virus
6/10/03 Affymetrix to Present at Thomas Weisel Partners Growth Forum
6/3/03 Affymetrix to Support AAAS Newcomb Cleveland Prize
6/2/03 Affymetrix to Webcast Annual Meeting of Stockholders
5/7/03 Affymetrix Japan K.K. Expands Access To GeneChip(R) Technology; Authorizes Four New Service Providers
5/7/03 Affymetrix to Present at Robert W. Baird & Co. 2003 Growth Stock Conference
5/6/03 Affymetrix Announces GeneChip(R) CustomSeq(TM) SARS Pathogen Detection And Resequencing Array
4/25/03 Affymetrix to Present at NASDAQ 6th Life Sciences Forum
4/23/03 Affymetrix Reports First Quarter Results
4/14/03 Affymetrix to Host Conference Call to Announce First Quarter 2003 Results
4/3/03 Affymetrix Updates First Quarter
3/18/03 Affymetrix to Present at Banc of America Securities Healthcare Conference
3/18/03 Affymetrix to Supply ParAllele Bioscience with GeneChip(R) Tag Arrays
3/10/03 Affymetrix Announces Advanced GeneChip(R) Brand Mouse and Rat Expression Arrays
3/4/03 Affymetrix Announces New Formats for GeneChip(R) Brand CustomExpress(TM) Arrays
2/27/03 Affymetrix to Present at Lehman Brothers Global Healthcare Conference
1/31/03 Affymetrix to Webcast Presentation From Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
1/30/03 Roche Licenses Affymetrix' GeneChip(R) Technology
1/29/03 Affymetrix to Host Conference Call to Discuss Clinical Genomics
1/29/03 Affymetrix Reports Record Revenue and Profits
1/22/03 Affymetrix and Boston University Medical Center Collaborate on Clinical Lung Cancer Study Using Microarrays
1/20/03 Affymetrix to Host Conference Call to Announce Fourth Quarter and Year End 2002 Results
1/6/03 Affymetrix Announces GeneChip(R) Scanner 3000
1/2/03 Affymetrix to Webcast Presentation from JP Morgan H&Q Healthcare Conference
12/9/02 Affymetrix Enters Into Strategic Relationship with Arcturus
12/6/02 Affymetrix, Stanford University and Incyte Resolve Patent Oppositions and Interferences
11/7/02 Affymetrix to Webcast Presentation at Credit Suisse First Boston Health Care Conference
10/24/02 Affymetrix to Webcast Presentation at Salomon Smith Barney Conference
10/23/02 Affymetrix Reports Record Product Revenue
10/22/02 Affymetrix Signs GeneChip(R) EasyAccess(TM) Silver Agreement With Schering-Plough Research Institute
10/16/02 Affymetrix to Introduce New GeneChip(R) CustomSeq(TM) Resequencing Array
10/14/02 Affymetrix to Host Conference Call to Announce Third Quarter 2002 Results
10/8/02 Affymetrix to Webcast Presentation at UBS Warburg Conference
10/4/02 Affymetrix Named 'Company of the Year' and Affymetrix Founder Awarded 'Most Masterful in Microarrays' by Genome Technology Magazine
9/30/02 Affymetrix and Ardais Collaborate to Advance Clinical Genomics
9/19/02 Affymetrix Founder and CEO Stephen Fodor Receives 2002 Innovation Award From The Economist
9/16/02 Whitehead Institute and Affymetrix Collaborate to Move Cancer Genomics Into the Clinic
9/13/02 Affymetrix and Woodrow Wilson Center Organize Symposium On Intellectual Property and the Human Genome
9/10/02 Affymetrix Names Steve Lombardi VP of Corporate Development
9/5/02 Affymetrix and Biotique Systems Collaborate to Provide Open Access To Human Transcriptome Data
9/4/02 Nasdaq Life Sciences Forum Webcast Monday, September 16, 8.30 a.m. - 12.30 p.m. GMT
9/2/02 Affymetrix to Open Tokyo Office to Serve Growing Demand for GeneChip(R) Brand Products
8/7/02 Scientists Unite to Accelerate Huntington's Disease Research
7/24/02 Affymetrix Reports Record Second Quarter Revenue
7/23/02 Affymetrix Names Dr. Trevor J. Nicholls Chief Commercial Officer
7/22/02 Affymetrix Receives NCI Grant to Uncover Hidden Genome Activity
7/15/02 Affymetrix to Host Conference Call to Announce Second Quarter 2002 Results
7/10/02 Affymetrix Signs GeneChip(R) EasyAccess(TM) Silver Agreement With Immunex
6/13/02 Affymetrix Signs GeneChip(R) EasyAccess(TM) Silver Agreement With Organon
6/10/02 New Affymetrix Sample Preparation Kit Streamlines Target Labeling in Expression Analysis Research
6/3/02 Affymetrix to Host Live Webcast of Annual Meeting
5/20/02 Affymetrix to Host Live Webcast of Investor Day
4/24/02 Affymetrix Reports Record First Quarter Revenue
4/17/02 Affymetrix to Host Conference Call to Announce First Quarter 2002 Results
4/15/02 Affymetrix and TIGR Announce New GeneChip(R) Arabidopsis Array Design
3/26/02 Monsanto to Use Custom GeneChip(R) Arrays for Agriculture Applications
1/30/02 Affymetrix Reports Record Financial Results for Fourth Quarter and Fiscal Year 2001
1/23/02 Affymetrix to Host Conference Call to Announce Fourth Quarter and Year End 2001 Results
1/21/02 Affymetrix Launches First Commercial Human DNA Array to Use Draft Of Human Genome
12/21/01 Affymetrix and Incyte Genomics Settle All Patent Infringement Litigation
10/25/01 Affymetrix and Hyseq Settle All Patent Litigation
10/24/01 Affymetrix Reports Third Quarter Results
10/24/01 Affymetrix and Millennium Partner to Advance Gene Expression Array Technology
10/15/01 Affymetrix Advances in Incyte Litigation
10/10/01 Affymetrix to Host Conference Call to Announce Third Quarter 2001 Results
9/10/01 Affymetrix and GlaxoSmithKline Expand Agreement for GeneChip(R) Technology
8/7/01 Orchid And Affymetrix Expand Genotyping Licensing And Distribution Agreements
7/25/01 Affymetrix Reports Second Quarter Results
7/25/01 Affymetrix Expands Management Team
7/25/01 Affymetrix Launches NetAffx(TM) Website
7/24/01 Affymetrix Announces New CustomExpress(TM) Array Program
7/24/01 Personalizing Medicine: deCODE and Affymetrix to Collaborate on DNA-Based Tests to Optimize the Effectiveness of Treatments for Major Diseases
7/16/01 Affymetrix to Host Conference Call to Announce Second Quarter 2001 Results
6/11/01 Affymetrix Updates Financial Expectations
5/2/01 Affymetrix Granted Significant Patent on Array Readers
4/25/01 Affymetrix Reports First Quarter Results
4/19/01 Affymetrix to Host Conference Call to Announce First Quarter 2001 Results
4/9/01 Affymetrix and GeneData Enter Into Co-Marketing Agreement
4/2/01 Perlegen Completes $100 Million Financing
3/23/01 Affymetrix and OGT Settle Litigation
2/5/01 Affymetrix Reports Record 2000 Results
2/1/01 Affymetrix and MWG-Biotech Expand Distribution Agreement
1/25/01 Court Ruling Strengthens Affymetrix Patent Estate
1/19/01 Affymetrix to Host Conference Call to Announce Fourth Quarter And 2000 Year-End Results
1/10/01 Affymetrix and Lexicon Genetics Sign GeneChip(R) BiotechAccess(TM) Agreement
1/4/01 Affymetrix Grants Genomic Solutions a License to Commercialize Low and Medium Density DNA Arrays
11/28/00 Affymetrix and the Medical Research Council Sign Microarray Internal Use License Agreement
11/10/00 Interim Verdict Announced in Oxford Gene Technology Litigation
11/2/00 U.K. Court of Appeal Rules Affymetrix Owns OGT Patent License
10/31/00 Affymetrix Completes Acquisition of Neomorphic
10/24/00 Affymetrix Reports Profitable Quarter
10/18/00 Affymetrix 3Q 2000 Conference Call Invitation
10/6/00 Affymetrix to Participate in New Mouse Genome Consortium
10/3/00 Affymetrix Announces Formation of New Genomics Company: Perlegen Sciences
10/2/00 Affymetrix Announces Definitive Merger Agreement With Neomorphic, Inc
9/11/00 Affymetrix Grants Takara Shuzo Co., Ltd. a License to Commercialize DNA Arrays
8/31/00 Affymetrix and the Cystic Fibrosis Foundation to Develop GeneChip(R) Arrays For Pseudomonas Studies in Cystic Fibrosis Patients
8/21/00 Affymetrix Responds to Incyte Genomics Lawsuit
8/10/00 Affymetrix and deCODE genetics Sign GeneChip® BiotechAccess™ Agreement
8/2/00 Affymetrix Announces Confirmation of Favorable Decision in Hyseq Litigation
7/31/00 Affymetrix Launches GeneChip® Arabidopsis Genome Array
7/24/00 Affymetrix Reports Record Second Quarter Results
- Company Introduces Whole Genome Scanning Project -
7/21/00 Affymetrix Announces Two-for-One Stock Split
7/14/00 Deltagen to Use Affymetrix GeneChip® Arrays to Build Murine Gene Expression Databases
7/10/00 Affymetrix Signs GeneChip® EasyAccess™ Silver Agreement With Janssen Research Foundation and The R.W. Johnson Pharmaceutical Research Institute
7/6/00 Affymetrix Announces that PE Corporation has Filed Suit Against Affymetrix on Chemical Synthesis Patents
6/26/00 Affymetrix Salutes Completion of Human Genome Sequencing
6/16/00 Affymetrix Grants MWG-Biotech a License to Commercialize DNA Arrays
6/12/00 Affymetrix Expands GeneChip® Supply Agreement with Merck to EasyAccess™ Silver Status
5/31/00 Affymetrix and Procter and Gamble Sign GeneChip® EasyAccess™ Silver Agreement
4/25/00 InphoGene to Use Affymetrix GeneChip® Arrays to Build Cardiovascular and Pulmonary Disease Gene Expression Databases
4/20/00 Affymetrix Reports Record First Quarter Results
4/19/00 Affymetrix Launches New Human GeneChip® Expression Arrays for Analysis of >60,000 Gene Sequences
4/18/00 Affymetrix Introduces GeneChip® GenFlex™ Tag Array
4/7/00 Affymetrix to Appeal U.K. Court Ruling on Transfer of Patent License
4/6/00 Affymetrix and AMDeC Sign AcademicAccess™ Preferred Agreement
4/4/00 Affymetrix Introduces GeneChip® E. coli Genome Probe Array
3/22/00 Affymetrix Grants NEN A License to Commercialize Low and Medium Density DNA Arrays
2/11/00 Affymetrix, Inc. Announces Exercise of Option
2/10/00 Affymetrix Completes Acquisition of Genetic Microsystems
2/9/00 Affymetrix, Inc. Raises $175 Million in Convertible Subordinated Debt
2/7/00 Affymetrix, Inc. Announces Proposed $150 Million Convertible Subordinated Note Offer
2/7/00 Affymetrix Announces Amendment to Its Shareholder Rights Plan
2/3/00 Affymetrix Reports Record Fourth Quarter and Year End Results
2/1/00 Affymetrix Introduces New GeneChip® Probe Arrays for Gene Expression Monitoring in Human Cancer and Yeast
1/11/00 Affymetrix and Novartis sign GeneChip® EasyAccess™ Sliver Agreement
12/15/99 Affymetrix and Orchid Announce Alliance to Develop and Commercialize New GeneChip® Genotyping Assays
12/7/99 Affymetrix Purchases Stingray Expression Analysis Software from Molecular Applications Group
11/29/99 Sankyo Enters EasyAccess™ Silver Agreement to Gain Access to Affymetrix' GeneChip® Technology
11/4/99 Affymetrix Announces Four New AcademicAccess™ Customers
11/1/99 Qiagen and Affymetrix To Develop and Commercialize Nucleic Acid Sample Preparation Solutions For GeneChip® Arrays
10/27/99 Affymetrix Announces Favorable Markman Decision
10/18/99 Affymetrix Reports Third Quarter Results
9/18/99 Affymetrix Launches New Genome Scanning
9/17/99 Affymetrix, Inc. Announces Exercise of Option
9/17/99 Affymetrix Raises $125 Million in Convertible Subordinated Debt Placement
9/14/99 Affymetrix Announces Proposed $100 Million Convertible Subordinated Note Offer
9/13/99 Affymetrix to Acquire Genetic Microsystems
9/10/99 Patent Office Announces Decision in Affymetrix' Favor in both Interferences with Incyte Pharmaceuticals
9/9/99 Affymetrix and The Novartis Institute for Functional Genomics enter Supply Agreement and Research Collaboration for GeneChip® Technology
9/7/99 Affymetrix Commences Commercial Shipments of GeneChip® Products From West Sacramento Manufacturing Facility
8/31/99 Affymetrix Introduces GeneChip® HuSNP™ Mapping Assay
8/26/99 Affymetrix Promotes Siegel to President
8/23/99 Affymetrix Introduces GeneChip® Expression Arrays for Rat Genome and Rat Toxicology, and Complementary Arrays for Sample Verification
8/5/99 Affymetrix Announces Glaxo Wellcome's Election to Convert Its Series AA Preferred Stock into Affymetrix Common Stock
7/28/99 Affymetrix Reports Second Quarter Results
7/22/99 Six National Institutes of Health (NIH) Institutes Gain Broad Access to Affymetrix GeneChip® Technology News Release
7/14/99 Washington University enters AcademicAccess™ Agreement with Affymetrix to Obtain Widespread Access to GeneChip® Technology
7/13/99 Affymetrix Appoints Adrian Hennah to Board of Directors
7/6/99 Boehringer Ingelheim and Affymetrix Sign GeneChip® EasyAccess™ Silver Agreement
7/1/99 Whitehead Functional Genomics Consortium Announces Technology Contribution to SNP Consortium
6/23/99 Stanford University enters AcademicAccess™ Agreement with Affymetrix to Obtain Widespread University Access to GeneChip® Technology
6/15/99 Affymetrix and Metabolex enter GeneChip® Custom Access Agreement
6/14/99 The University Of California System Enters Agreement Under Affymetrix' AcademicAccess™ Program
6/7/99 Affymetrix Purchases License to Southern DNA Array Patents
6/1/99 Takeda and Affymetrix Enter DNA Array Internal Use License Agreement
5/6/99 Affymetrix Announces Court Decision on Preliminary Injunction and Summary Judgement Motions
5/3/99 Affymetrix Reports First Quarter Results
4/21/99 Smithkline Beecham and Affymetrix Sign Internal Use License Agreement For Spotted Arrays And GeneChip® EasyAccess™ Silver Agreement
4/20/99 The National Cancer Institute and Affymetrix Announce Agreement to Make GeneChip® Technology Accessible to The Academic Community
4/12/99 Affymetrix Expands GeneChip® Supply Agreement With Astra AB to EasyAccessTM-Silver Status
4/12/99 Affymetrix Provides Update on Litigation Against Incyte
3/30/99 Affymetrix Expands Agreement with Pfizer to Include GeneChip® EasyAccessTM Silver Status
3/25/99 Affymetrix Announces Closing of $32.5 Million Private Placement
3/15/99 Affymetrix Announces $32.5 Million Private Placement
2/16/99 Affymetrix and Parke-Davis Expand GeneChip® Array Supply Agreement to EasyAccess™ Silver Status
2/10/99 Eos and Affymetrix enter DNA Array Internal Use License Agreement
2/2/99 Affymetrix Reports Fourth Quarter and Fiscal 1998 Results
1/14/99 Affymetrix And Hoechst Marion Roussel Expand GeneChip® Array Supply Agreement To EasyAccess™ Gold Status
1/13/99 Affymetrix and Rhône-Poulenc Rorer Sign EasyAccess™ Silver Agreement For Supply Of Gene Expression Monitoring Arrays
1/12/99 Affymetrix Appoints Ronald Verdoorn To Head Global Manufacturing Operations
1/11/99 Gene Logic to Use Affymetrix GeneChip® Arrays to Build Gene Expression Database Products
1/6/99 Affymetrix Appoints Rava to Senior Vice President and Chief Technology Officer
12/2/98 Affymetrix And Research Genetics Sign GeneChip® Array Services Agreement
12/1/98 Affymetrix And Rosetta Inpharmatics Enter DNA Array Internal Use License Agreement
11/12/98 Affymetrix and Human Genome Sciences Enter Agreement to Permit Commercialization of GeneChip® Arrays Based on HGSI Database Sequences
10/28/98 Affymetrix Reports Third Quarter Results
9/18/98 Affymetrix Launches New Genome Scanning GeneChip® Expression Products
9/9/98 Affymetrix and Lilly Sign EasyAccess™ Agreement for Supply of Gene Expression Monitoring Arrays
9/8/98 Affymetrix and Molecular Applications Group to Develop New Intergrated Software Tools for Complex Genetic Data Analysis
9/2/98 Affymetrix Announces American Home Products Exercises Option to Become Affymetrix' Latest EasyAccess™ Customer
9/1/98 Affymetrix Issued U.S. Patent Covering Gene Expression Monitoring
8/31/98 Affymetrix and Hewlett Packard Extend Manufacturing Agreement for GeneArray™ Scanners
8/18/98 Affymetrix Issued U.S. Patent Covering GeneChip® Technology
8/5/98 Affymetrix Announces DNA Array Agreements with Beckman Coulter
7/29/98 Affymetrix Reports Second Quarter Results
6/4/98 Human Genome Sciences and Affymetrix Announce Agreement to Develop Bacterial GeneChip® Probe Arrays
5/1/98 Affymetrix and Eos Biotechnology Enter Strategic Agreements
4/27/98 Roche Molecular Systems and Affymetrix Combine GeneChip® Technology and PCR for New Diagnostic Products
4/22/98 Affymetrix and Howard Hughes Medical Institute Enter GeneChip® Academic EasyAccess™ Agreement
4/20/98 Sue Siegel Named Senior Vice President Marketing and Sales at Affymetrix
4/15/98 Affymetrix Announces Closing of Sale of $50 Million of Series AA Preferred Stock
3/25/98 Affymetrix and Oncormed to Co-Develop and Commercialize Gene Expression Database Under Expanded Collaboration
3/10/98 Affymetrix Announces Definitive Agreement to Sell $50 Million of Series AA Preferred Stock
3/10/98 Affymetrix Announces Definitive Agreement to Sell $50 Million of Series AA Preferred Stock
2/5/98 Affymetrix Reports Fiscal 1997 and Fourth Quarter Results
2/5/98 Pangea Systems to Join Affymetrix and Molecular Dynamics in Standardizing Genetic Analysis Tools
1/26/98 Progenitor and Affymetrix Form GeneChip Research Collaboration for Asthma
1/21/98 Affymetrix and bioMerieux Expand Collaboration to Include HIV Genotyping And Microbial Contamination Testing
1/13/98 Affymetrix and Genetics Institute Enter EasyAccess Agreement
1/6/98 Affymetrix Files Patent Infringement Suit Against Synteni and Incyte
12/17/97 Affymetrix and Metabolex Sign Agreement for Supply of Gene Expression Monitoring Arrays
12/11/97 Affymetrix and Novartis Sign Agreement for Supply of Gene Expression Monitoring Arrays
12/2/97 Affymetrix and Amersham Pharmacia Biotech Enter Into Distribution Agreement For GeneChip Products
12/2/97 Affymetrix and Molecular Dynamics Enter Agreements to Expand Access to DNA Array-Based Genetic Analysis Tools
11/14/97 Dr. Alejandro Zaffaroni to Retire From Affymetrix and ALZA Boards
11/6/97 Affymetrix Launches GeneChip(R) Polymorphism Cytochrome P450 Assay
10/31/97 Affymetrix Withdraws Secondary Offering
10/24/97 Affymetrix, Inc. Reports Third Quarter Results
10/17/97 Affymetrix, Inc. Files Public Offering of 1.5 Million Shares of Common Stock
9/25/97 Affymetrix and Parke-Davis Sign Agreement for Supply of Gene Expression Monitoring Arrays
8/25/97 Roche Signs as Initial Subscriber to `Easy Access' Program For Affymetrix GeneChip(R) Arrays
8/14/97 Affymetrix and Pfizer Sign Agreement for Supply of Gene Expression Monitoring Arrays
7/24/97 Affymetrix, Inc. Reports Second Quarter Results
7/2/97 Affymetrix Launches GeneChip(R) p53 Assay
4/29/97 Consortium to Fund Functional Genomics Group at Whitehead/MIT Center for Genome Research
4/18/97 Affymetrix, Inc. Reports First Quarter Results
3/11/97 Affymetrix Names Steve Fodor President and CEO
3/3/97 Patent Infringement Suit Filed by Hyseq Against Affymetrix
2/26/97 Affymetrix Appoints Hurwitz Chief Financial Officer
2/24/97 Affymetrix and HP Launch GeneArray Scanner; Companies Redefine Alliance
1/27/97 Affymetrix and Glaxo Wellcome Sign HIV Database Agreement
1/27/97 Affymetrix, Inc. Reports 1996 Year End Financial Results
1/9/97 Roche Bioscience and Affymetrix Sign DNA Chip Agreement for Gene Expression Monitoring
11/19/96 Incyte and Affymetrix Link Technologies to Commercialize New Chip-Based Genomic Products
10/18/96 Affymetrix and bioMerieux Vitek Sign GeneChip(TM) Bacteriology Agreement
10/17/96 Affymetrix, Inc. Reports Third Quarter Results
10/16/96 F. Hoffmann-La Roche and Affymetrix Sign DNA Chip Agreement for Gene Expression Monitoring
10/10/96 Affymetrix Signs DNA Chip Agreement With Merck & Co. Inc. For Gene Expression Monitoring
9/30/96 Affymetrix and OncorMed to Develop Innovative DNA Chip Based Cancer Diagnostics
7/19/96 Affymetrix Inc. Reports Second Quarter Results
6/6/96 Affymetrix Inc. Announces Initial Public Offering Of Common Stock

RESOURCES
Corporate Donations
Ethics & Policy
Events
Scientific Publications
888 DNA CHIP (888 362 2447) +44 (0) 1628 552550 feedback terms of use privacy policy contact